Allgens(SH:688613) Sou Hu Cai Jing·2025-12-16 00:28Core Viewpoint - The stock of Aojing Medical (688613) has shown a slight increase of 1.93% on December 15, 2025, closing at 20.02 yuan, with notable fluctuations in capital flow and financing activities [1][2]. Group 1: Stock Performance and Capital Flow - On December 15, 2025, Aojing Medical's stock closed at 20.02 yuan, with a trading volume of 40,400 hands and a total transaction amount of 80.583 million yuan [1]. - The capital flow data indicates a net inflow of 1.763 million yuan from main funds, accounting for 2.19% of the total transaction amount, while retail investors experienced a net outflow of 4.106 million yuan, representing 5.09% of the total [1][2]. - Over the past five days, the stock has experienced fluctuations in capital flow, with the highest net inflow from main funds recorded at 20.0116 million yuan on December 10, 2025 [2]. Group 2: Financing and Margin Trading - On December 15, 2025, the financing buy-in amounted to 12.8433 million yuan, with a net financing buy-in of 6.7929 million yuan, while the total financing balance reached 163 million yuan [3]. - The financing data over the past five days shows a trend of fluctuating net financing buy-ins, with a peak of 9.6018 million yuan on December 9, 2025 [3]. Group 3: Company Financial Performance - Aojing Medical reported a main revenue of 156 million yuan for the first three quarters of 2025, reflecting a year-on-year increase of 5.22%, with a net profit of 13.9406 million yuan, up 185.19% [5]. - The company's gross profit margin stands at 68.9%, significantly higher than the industry average of 51.02%, indicating strong operational efficiency [5]. - The company's total market capitalization is 2.743 billion yuan, with a net asset value of 1.449 billion yuan, positioning it below the industry average in several key financial metrics [5].